Mathias Elsocht

Mr. Mathias Elsocht

M.E.
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MEMathias Elsocht
Mathias Elsocht
PGPhilippe Giron
Philippe Giron
LMLaila Maes
Laila Maes
WVWim Versées
Wim Versées
GGGustavo J. Gutierrez
Gustavo J. Gutierrez
Steven  BalletSteven Ballet
Steven Ballet
Lung cancer is one of the most frequently diagnosed cancers accounting for the highest number of cancer-related deaths in the world. Despite significant progress including targeted therapies and immunotherapy, the treatment of advanced lung cancer remains challenging. Targeted therapies are highly efficacious at prolonging life, but not curative. In prior work we have identified Ubiquitin Specific Protease 13 (USP13) as a potential target to significantly enhance the efficacy of mutant EGFR inhibition. The current study aimed to develop lead molecules for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) by developing potent USP13 inhibitors initially starting from Spautin-1, the only available USP13 inhibitor. A SAR study was performed which revealed that increasing the chain length between the secondary amine and phenyl group and introducing a halogen capable of inducing a halogen bond at position 4’ of the phenyl group, dramatically increased the activity. However, we could not confirm the binding between Spautin-1 (or its analogues) and USP13 using isothermal titration calorimetry (ITC) or thermal shift assay (TSA) but do not exclude binding under physiological conditions. Nevertheless, we found that the anti-proliferative activity displayed by Spautin-1 towards EGFR-mutant NSCLC cells in vitro was at least partially associated with kinase inhibition. In this work, we present N-[2-(substituted-phenyl)ethyl]-6-fluoro-4-quinazolinamines as promising lead compounds for the treatment of NSCLC. These analogues are significantly more effective towards EGFR-mutant NSCLC cells than Spautin-1 and act as potent never in mitosis A related kinase 4 (NEK4) inhibitors (IC50~1 µM) with moderate selectivity over other kinases.

15 June 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CHCharlie Hollanders
Charlie Hollanders
MEMathias Elsocht
Mathias Elsocht
OPOlivier Van der Poorten
Olivier Van der Poorten
MJMouhamad Jida
Mouhamad Jida
EREvelien Renders
Evelien Renders
Steven  BalletSteven Ballet
Steven Ballet
We report the use of 3-substituted 2-isocyanopyridines as convertible isocyanides in Ugi four-component reactions. The N -(3-substituted pyridin-2-yl)amide Ugi products can be cleaved by amines, alcohols, and water with Zn(OAc) 2 as catalyst.

18 November 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MEMathias Elsocht
Mathias Elsocht
PGPhilippe Giron
Philippe Giron
JGJacques De Grève
Jacques De Grève
Steven  BalletSteven Ballet
Steven Ballet

6 July 2021 in Synlett
Verified
Journal Article
Closed access
PDF file
RHRobin Van Den Hauwe
Robin Van Den Hauwe
MEMathias Elsocht
Mathias Elsocht
Steven  BalletSteven Ballet
Steven Ballet
CHCharlie Hollanders
Charlie Hollanders
An efficient three-step synthesis towards 3-amino-1,4-benzodiazepin-2-one derivatives is presented. The versatile Ugi-4-component reaction (Ugi-4CR) and Boc deprotection is followed by a ligand-free Ullmann condensation. This protocol allows the rapid construction of a diverse array of substituted 1,5-benzodiazepinones. Since Ugi-based products are typically limited by their ‘inert’ C-terminal amides, the use of a convertible (‘cleavable’) isocyanide was envisaged and resulted in building blocks that can be made SPPS compatible. To demonstrate the potential of this novel synthetic route, the design and preparation of novel phenylurea-1,5-benzodiazepin-4(5H)-one dipeptide mimetics with potential CCK2-antagonist properties is reported.

1 January 2018
Verified
Conference Paper
Closed access
MEMathias Elsocht
Mathias Elsocht
KHKarlijn Hollanders
Karlijn Hollanders
OPOlivier Van der Poorten
Olivier Van der Poorten
MJMouhamad Jida
Mouhamad Jida
BMBert Maes
Bert Maes
SBSteven Ballet
Steven Ballet